Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?
touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY
Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care.
The experts
Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain
Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands
Dr…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.